Emcure Pharmaceuticals Ltd EMCURE.NS
₹1,833.50 ₹31.20 (1.67%) 1D
Last Updated: Oct 09, 12:00 AM·NSE
Pricing for IN stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Emcure Pharmaceuticals Ltd Stock Halal?
Shariah Compliance Analysis of EMCURE.NS Stock
India Health Care Mid Cap Yes. As of October 2026, Emcure Pharmaceuticals Ltd (EMCURE.NS) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Emcure Pharmaceuticals Ltd passes Musaffa's business and financial screening criteria.
Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. The company is headquartered in Pune, Maharashtra and currently employs 6,731 full-time employees. The company went IPO on 2024-07-10. The company offers a range of products and services under formulations, biologics and APIs. The company operates across a wide scope of areas, including gynecological, cardiology, antivirals, vitamins, pain/analgesics, anti-neoplastic, diabetes, anti-infective, respiratory, CNS and nephrology. Its brands include OROFER (Gynecological), BEVON (Vitamins), ZOSTUM (Anti- infectives), Ferium (Gynecological), EXHEP (Cardiovascular), Maxtra (Respiratory) and Pause (Blood-Related). Its API products include S-Amlodipine, Dydrogesterone, Ferric Carboxymaltose, Ferrous Ascorbate and Eribulin. Its biologics business offers various products, including Elaxim (cardiology), Vintor (nephrology), Xgrast (anti-neoplastic) and Pegex (anti- neoplastic). The company has developed two platforms: Mammalian and Microbial.
EMCURE.NS Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Emcure Pharmaceuticals Ltd is classified as halal.
HALALEmcure Pharmaceuticals Ltd (EMCURE.NS) Chart
Fetching Price Chart...
Financial Metrics & Statements of Emcure Pharmaceuticals Ltd (EMCURE.NS)
FAQ's for Emcure Pharmaceuticals Ltd (EMCURE.NS)
- As of October 2026, Emcure Pharmaceuticals Ltd EMCURE.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Emcure Pharmaceuticals Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Emcure Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Emcure Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Emcure Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Emcure Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Emcure Pharmaceuticals Ltd (EMCURE.NS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
